|
1
|
Diversity of receptors binding HIV on dendritic cell subsets.
|
Nat Immunol
|
2002
|
4.63
|
|
2
|
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.
|
Blood
|
2003
|
3.40
|
|
3
|
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo.
|
J Immunol
|
2007
|
2.41
|
|
4
|
CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency.
|
Blood
|
2007
|
2.21
|
|
5
|
IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling.
|
Nat Commun
|
2013
|
1.71
|
|
6
|
Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy.
|
J Infect Dis
|
2010
|
1.33
|
|
7
|
The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.
|
J Immunol
|
2003
|
1.32
|
|
8
|
Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.
|
Retrovirology
|
2011
|
1.31
|
|
9
|
Persistent immune activation in chronic HIV infection: do any interventions work?
|
AIDS
|
2013
|
1.24
|
|
10
|
Identification of lineage relationships and novel markers of blood and skin human dendritic cells.
|
J Immunol
|
2012
|
1.21
|
|
11
|
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
|
J Infect Dis
|
2013
|
1.16
|
|
12
|
Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
|
PLoS One
|
2011
|
1.15
|
|
13
|
Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.
|
J Immunol
|
2012
|
1.15
|
|
14
|
Heterogeneity of freshly isolated human tonsil dendritic cells demonstrated by intracellular markers, phagocytosis, and membrane dye transfer.
|
Cytometry
|
2002
|
1.08
|
|
15
|
The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.
|
AIDS
|
2009
|
1.04
|
|
16
|
Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2008
|
1.02
|
|
17
|
The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.
|
Hepatology
|
2007
|
1.00
|
|
18
|
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.
|
J Virol
|
2009
|
0.99
|
|
19
|
Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection.
|
J Immunol
|
2002
|
0.99
|
|
20
|
The search for an HIV cure: tackling latent infection.
|
Lancet Infect Dis
|
2013
|
0.98
|
|
21
|
Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.
|
PLoS Pathog
|
2013
|
0.97
|
|
22
|
Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.
|
J Virol
|
2010
|
0.97
|
|
23
|
Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.
|
PLoS One
|
2011
|
0.96
|
|
24
|
Detection and properties of the human proliferative monocyte subpopulation.
|
J Leukoc Biol
|
2006
|
0.95
|
|
25
|
Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.
|
AIDS
|
2013
|
0.94
|
|
26
|
Tissue dendritic cells as portals for HIV entry.
|
Rev Med Virol
|
2013
|
0.92
|
|
27
|
The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the post-acute stage of infection.
|
Retrovirology
|
2007
|
0.90
|
|
28
|
A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1.
|
J Virol Methods
|
2010
|
0.89
|
|
29
|
Genetic modulation of TLR8 response following bacterial phagocytosis.
|
Hum Mutat
|
2010
|
0.88
|
|
30
|
Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity.
|
J Infect Dis
|
2003
|
0.88
|
|
31
|
HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
|
J Leukoc Biol
|
2010
|
0.88
|
|
32
|
Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitro.
|
Retrovirology
|
2011
|
0.87
|
|
33
|
The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player.
|
Clin Immunol
|
2011
|
0.85
|
|
34
|
Cytokine profiling in abacavir hypersensitivity patients.
|
Antivir Ther
|
2008
|
0.83
|
|
35
|
Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation.
|
Eur J Immunol
|
2013
|
0.83
|
|
36
|
Iatrogenic Cushing's syndrome in an HIV-infected patient treated with ritonavir and inhaled fluticasone.
|
AIDS
|
2005
|
0.83
|
|
37
|
Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
|
AIDS
|
2016
|
0.82
|
|
38
|
Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
|
Eur J Immunol
|
2003
|
0.82
|
|
39
|
Human thymic dendritic cells: regulators of T cell development in health and HIV-1 infection.
|
Clin Immunol
|
2007
|
0.81
|
|
40
|
Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection.
|
J Leukoc Biol
|
2013
|
0.81
|
|
41
|
Interferon-gamma therapy activates human monocytes for enhanced phagocytosis of Mycobacterium avium complex in HIV-infected individuals.
|
HIV Clin Trials
|
2004
|
0.80
|
|
42
|
Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report.
|
J Med Case Rep
|
2009
|
0.80
|
|
43
|
Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.
|
Immunol Cell Biol
|
2003
|
0.80
|
|
44
|
HIV persistence: chemokines and their signalling pathways.
|
Cytokine Growth Factor Rev
|
2012
|
0.80
|
|
45
|
Human immunodeficiency virus (HIV)-1 integration sites in viral latency.
|
Curr HIV/AIDS Rep
|
2015
|
0.79
|
|
46
|
Salmonella enterica Serovar Typhimurium infection of dendritic cells leads to functionally increased expression of the macrophage-derived chemokine.
|
Infect Immun
|
2005
|
0.79
|
|
47
|
Early events of HIV-1 infection: can signaling be the next therapeutic target?
|
J Neuroimmune Pharmacol
|
2011
|
0.78
|
|
48
|
Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.
|
Clin Immunol
|
2009
|
0.77
|
|
49
|
Spleen registry may help reduce the incidence of overwhelming postsplenectomy infection in Victoria.
|
Med J Aust
|
2010
|
0.77
|
|
50
|
Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
|
AIDS
|
2016
|
0.76
|
|
51
|
HIV persistence and T-cell activation in blood, rectal and lymph node tissue in HIV-infected individuals receiving suppressive ART.
|
J Infect Dis
|
2017
|
0.75
|
|
52
|
Entry of HIV in primary human resting CD4(+) T cells pretreated with the chemokine CCL19.
|
AIDS Res Hum Retroviruses
|
2014
|
0.75
|
|
53
|
[The effect of specific virus delivering of Langerhans cell for the M-tropic HIV infection].
|
Zhonghua Yi Xue Za Zhi
|
2003
|
0.75
|
|
54
|
Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
|
AIDS
|
2017
|
0.75
|
|
55
|
Construction and expression of a Rev-dependent TNF-R1 expressing HIV-infected-cell injurious vectors.
|
Chin Med J (Engl)
|
2005
|
0.75
|
|
56
|
The influence of splenectomy on the infectious complications and outcomes of people with HIV: marked, sustained elevation in risk of severe infection with bacteria including Streptococcus pneumoniae.
|
J Acquir Immune Defic Syndr
|
2010
|
0.75
|